Osaic Holdings
ADIL

Osaic Holdings’s Adial Pharmaceuticals ADIL Stock Holding History

Osaic Holdings’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-100
Closed -$3.33K – 7394
2024
Q1 		$3.33K Buy
100
+75
+300% +$2.81K ﹤0.01% 6268
2023
Q4 		$1.15K Hold
25
– – ﹤0.01% 6706
2023
Q3 		$1.71K Sell
25
-13
-34% -$1.53K ﹤0.01% 6681
2023
Q2 		$5K Buy
38
+1
+3% +$181 ﹤0.01% 6307
2023
Q1 		$8.09K Buy
37
+24
+185% +$5.82K ﹤0.01% 6100
2022
Q4 		$2K Hold
13
– – ﹤0.01% 6603
2022
Q3 		$3K Hold
13
– – ﹤0.01% 6568
2022
Q2 		$11K Hold
13
– – ﹤0.01% 6000
2022
Q1 		$25K Hold
13
– – ﹤0.01% 5546
2021
Q4 		$22K Hold
13
– – ﹤0.01% 5716
2021
Q3 		$35K Hold
13
– – ﹤0.01% 5376
2021
Q2 		$21K Hold
13
– – ﹤0.01% 5619
2021
Q1 		$20K Buy
13
+5
+63% +$7.56K ﹤0.01% 5458
2020
Q4 		$9K Sell
8
-2
-20% -$2.36K ﹤0.01% 5544
2020
Q3 		$9K Hold
10
– – ﹤0.01% 5303
2020
Q2 		$9K Sell
10
-3
-23% -$2.71K ﹤0.01% 5215
2020
Q1 		$10K Buy
+13
New +$13.9K ﹤0.01% 4987

Other funds holding ADIL

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings's ADIL Position: Q2 2024 in Review

Osaic Holdings sold out of Adial Pharmaceuticals (ADIL) in Q2 2024, closing a stake of 100 shares — an estimated $3.33K sold.

Osaic Holdings first reported a position in ADIL in Q1 2020 and held it in 17 quarters. The position peaked at $35K in Q3 2021. 14 funds tracked by Wall St. Rank hold ADIL as of Q2 2024.

  • Osaic Holdings reported no remaining Adial Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Osaic Holdings sold 100 Adial Pharmaceuticals shares in Q2 2024, an estimated $3.33K.
  • Osaic Holdings first reported a position in Adial Pharmaceuticals in Q1 2020 and held it in 17 quarters.
  • Osaic Holdings's Adial Pharmaceuticals position peaked at $35K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q2 2024.

Based on Osaic Holdings's 13F filing for Q2 2024, filed 13 Aug 2024.